Moderna was hit with a new patent lawsuit on Wednesday in Delaware federal court from Northwestern University, which accused ...

UBS analyst Jo Walton maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of p1,580.00. The ...

Barclays analyst Emily Field maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £15.50.

A persistent, often progressive, lung disease, COPD results from chronic inflammation that leads to structural changes ...

Hindustan Unilever (HUL)- the country's leading FMCG player will come up with its Q2 earnings on October 23, 2024 (Wednesday) ...

In patients with moderate to severe Crohn’s disease, guselkumab showed similar efficacy in both biologic-naive and ...

The settlement, announced on Wednesday, resolves 93% of all Zantac cases in state courts against GlaxoSmithKline.

Healthcare decision-makers are facing significant challenges that will intensify in the coming years as they work to address ...

GlaxoSmithKline Pharma, celebrating 100 years in India, is shifting to a specialty-focused model by entering the oncology ...

GlaxoSmithKline sued Moderna in Delaware federal court on Tuesday for allegedly violating GSK's patent rights in messenger ...

He then served as CEO of Reliant Pharmaceuticals, helping lead the company to its acquisition by GlaxoSmithKline in 2007. He ...